ZM12176A1 - Pharmacologically active compounds - Google Patents

Pharmacologically active compounds

Info

Publication number
ZM12176A1
ZM12176A1 ZM121/76A ZM12176A ZM12176A1 ZM 12176 A1 ZM12176 A1 ZM 12176A1 ZM 121/76 A ZM121/76 A ZM 121/76A ZM 12176 A ZM12176 A ZM 12176A ZM 12176 A1 ZM12176 A1 ZM 12176A1
Authority
ZM
Zambia
Prior art keywords
active compounds
pharmacologically active
pharmacologically
compounds
active
Prior art date
Application number
ZM121/76A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZM12176A1 publication Critical patent/ZM12176A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZM121/76A 1975-10-02 1976-10-01 Pharmacologically active compounds ZM12176A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
ZM12176A1 true ZM12176A1 (en) 1977-07-21

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
ZM121/76A ZM12176A1 (en) 1975-10-02 1976-10-01 Pharmacologically active compounds

Country Status (36)

Country Link
JP (2) JPS5246087A (fr)
AR (1) AR221682A1 (fr)
AT (1) AT358045B (fr)
AU (1) AU504897B2 (fr)
BE (1) BE846452A (fr)
BG (1) BG25224A3 (fr)
CA (1) CA1067076A (fr)
CH (1) CH625801A5 (fr)
CS (1) CS203003B2 (fr)
DD (1) DD126563A5 (fr)
DE (1) DE2643670C2 (fr)
DK (1) DK442476A (fr)
ES (1) ES452060A1 (fr)
FI (1) FI61701C (fr)
FR (1) FR2326192A1 (fr)
GR (1) GR61307B (fr)
HU (1) HU175537B (fr)
IE (1) IE44845B1 (fr)
IL (1) IL50503A (fr)
IN (1) IN146736B (fr)
IT (2) IT1070839B (fr)
LU (1) LU75922A1 (fr)
MW (1) MW3476A1 (fr)
MX (1) MX4614E (fr)
NL (1) NL7609917A (fr)
NO (1) NO145792C (fr)
NZ (1) NZ181959A (fr)
OA (1) OA05445A (fr)
PH (1) PH13921A (fr)
PL (1) PL105828B1 (fr)
PT (1) PT65590B (fr)
RO (1) RO73511A (fr)
SE (1) SE431872B (fr)
YU (1) YU237276A (fr)
ZA (1) ZA765498B (fr)
ZM (1) ZM12176A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (fr) * 1980-03-29 1983-10-25 Thomas H. Brown Composes
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
JPS609755B2 (ja) 1985-03-12
DD126563A5 (fr) 1977-07-27
HU175537B (hu) 1980-08-28
OA05445A (fr) 1981-03-31
IL50503A (en) 1980-12-31
PT65590B (en) 1978-03-28
MX4614E (es) 1982-07-07
CA1067076A (fr) 1979-11-27
GR61307B (en) 1978-10-19
IT1070839B (it) 1985-04-02
NO145792C (no) 1982-06-02
JPS5635674B2 (fr) 1981-08-19
FI762803A (fr) 1977-04-03
DE2643670C2 (de) 1982-07-01
CS203003B2 (en) 1981-02-27
NL7609917A (nl) 1977-04-05
DE2643670A1 (de) 1977-04-14
ES452060A1 (es) 1977-10-01
FI61701B (fi) 1982-05-31
ATA711976A (de) 1980-01-15
NO145792B (no) 1982-02-22
SE431872B (sv) 1984-03-05
IE44845B1 (en) 1982-04-21
PL105828B1 (pl) 1979-11-30
IL50503A0 (en) 1976-11-30
FR2326192A1 (fr) 1977-04-29
RO73511A (fr) 1981-04-30
AU504897B2 (en) 1979-11-01
BG25224A3 (en) 1978-08-10
AR221682A1 (es) 1981-03-13
IE44845L (en) 1977-04-02
AT358045B (de) 1980-08-11
CH625801A5 (en) 1981-10-15
NO763371L (fr) 1977-04-05
PT65590A (en) 1976-10-01
JPS5246087A (en) 1977-04-12
FI61701C (fi) 1982-09-10
SE7610409L (sv) 1977-04-03
NZ181959A (en) 1978-07-28
ZA765498B (en) 1977-08-31
MW3476A1 (en) 1977-11-09
YU237276A (en) 1983-01-21
JPS5695186A (en) 1981-08-01
FR2326192B1 (fr) 1979-01-12
IN146736B (fr) 1979-08-25
IT7830708A0 (it) 1978-12-11
LU75922A1 (fr) 1977-05-06
PH13921A (en) 1980-11-04
DK442476A (da) 1977-04-03
AU1829576A (en) 1978-04-06
BE846452A (fr) 1977-03-22

Similar Documents

Publication Publication Date Title
ZA763652B (en) Pharmacologically active compounds
ZA767198B (en) Pharmacologically active compounds
PT65590B (en) Pharmacologically active compounds
PT67046A (en) Pharmacologically active compounds
ZM9876A1 (en) Pharmacologically active compounds
ZA7682B (en) Pharmacologically active compounds
ZA765331B (en) Novel pharmaceutically active compounds
ZA763686B (en) Pharmacologically active compounds
ZA771018B (en) Pharmacologically active compounds
ZA761324B (en) Pharmaceutically active compounds
ZM9776A1 (en) Pharmacologically active compounds
PT65839B (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
ZA774221B (en) Pharmacologically active compounds
ZA774220B (en) Pharmacologically active compounds
ZA774552B (en) Pharmacologically active compounds
ZA774500B (en) Pharmacologically active compounds
ZA77508B (en) Pharmacologically active compounds
ZA766201B (en) Pharmacologically active compounds
AU1059176A (en) Pharmacologically active compositions
ZM7377A1 (en) Pharmacologically active compounds
MW2676A1 (en) Pharmacologically active compounds
MW2776A1 (en) Pharmacologically active compounds
MW2876A1 (en) Pharmacologically active compounds